Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs

被引:409
作者
Gershanik, T
Benita, S
机构
[1] Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel
关键词
self-emulsifying; emulsion; microemulsion; dispersion; oral bioavailability; lipophilic drugs; positive charge;
D O I
10.1016/S0939-6411(00)00089-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main purpose of this review is to provide a current and general overview of the existing self-dispersing formulations resulting from dilution into emulsions, microemulsions and surfactant dispersions. The systematic approach used and the presentation of the Various physico-chemical and biopharmaceutical aspects should facilitate the comprehension of this interesting field and clarify the main considerations involved in designing and characterizing a specific self-dispersing drug delivery system. Studies have shown that the self-emulsification process is specific to the nature of the oil/surfactant pair, surfactant concentration, oil/surfactant ratio and temperature at which self-emulsification occurs. It was suggested that the ease of emulsification could be associated with the ease by which water penetrates into the various liquid crystalline (LC) or gel phases formed on the surface of the droplet. Numerous bioavailability studies carried out in animals and humans, reviewed in the present study, suggest that hydrophobic drugs are better absorbed when administered in self-dispersing lipid formulations (SDLFs). Examples which illustrate the beneficial use of SDLFs for drug absorption enhancement are presented. This review outlines SDLFs as one of the most promising approaches to overcome the formulation difficulties of these hydrophobic/lipophilic drugs. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 63 条
[51]   SELF-EMULSIFYING DRUG-DELIVERY SYSTEMS (SEDDS) WITH POLYGLYCOLYZED GLYCERIDES FOR IMPROVING IN-VITRO DISSOLUTION AND ORAL ABSORPTION OF LIPOPHILIC DRUGS [J].
SHAH, NH ;
CARVAJAL, MT ;
PATEL, CI ;
INFELD, MH ;
MALICK, AW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 106 (01) :15-23
[52]   ENHANCEMENT OF BIOAVAILABILITY OF A HYDROPHOBIC AMINE ANTI-MALARIAL BY FORMULATION WITH OLEIC-ACID IN A SOFT GELATIN CAPSULE [J].
STELLA, V ;
HASLAM, J ;
YATA, N ;
OKADA, H ;
LINDENBAUM, S ;
HIGUCHI, T .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (10) :1375-1377
[53]   INTESTINAL PERMEABILITY ENHANCEMENT - EFFICACY, ACUTE LOCAL TOXICITY, AND REVERSIBILITY [J].
SWENSON, ES ;
MILISEN, WB ;
CURATOLO, W .
PHARMACEUTICAL RESEARCH, 1994, 11 (08) :1132-1142
[54]   ENHANCED INTESTINAL-ABSORPTION OF CYCLOSPORINE IN RATS THROUGH THE REDUCTION OF EMULSION DROPLET SIZE [J].
TARR, BD ;
YALKOWSKY, SH .
PHARMACEUTICAL RESEARCH, 1989, 6 (01) :40-43
[55]   EFFECTS OF THE PHYSICOCHEMICAL PROPERTIES OF THE EMULSION FORMULATION ON THE BIOAVAILABILITY OF ETHYL 2-CHLORO-3-[4-(2-METHYL-2-PHENYLPROPYLOXY)PHENYL]PROPIONATE IN RATS [J].
TOGUCHI, H ;
OGAWA, Y ;
SHIMAMOTO, T .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (10) :2797-2800
[56]   GASTROINTESTINAL ABSORPTION OF ETHYL 2-CHLORO-3-[4-(2-METHYL-2-PHENYLPROPYLOXY)PHENYL]PROPIONATE FROM DIFFERENT DOSAGE FORMS IN RATS AND DOGS [J].
TOGUCHI, H ;
OGAWA, Y ;
IGA, K ;
YASHIKI, T ;
SHIMAMOTO, T .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (10) :2792-2796
[57]  
Tsuji Y, 1996, BIOL PHARM BULL, V19, P636
[58]   Non-ionic surfactant based vesicles (niosomes) in drug delivery [J].
Uchegbu, IF ;
Vyas, SP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 172 (1-2) :33-70
[59]  
VONDERSCHER J, 1994, TRANSPL P, V26, P2925
[60]  
WAKERLY MG, 1986, ACS SYM SER, V311, P242